$GYRE
GYRE THERAPEUTICS, INC.

2024 Q4 Form 10-Q Financial Statement

#000095017024126306 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $25.49M $0.00
YoY Change
Cost Of Revenue $958.0K $0.00
YoY Change
Gross Profit $24.53M $0.00
YoY Change
Gross Profit Margin 96.24%
Selling, General & Admin $17.52M $2.410M
YoY Change 627.05% -45.73%
% of Gross Profit 71.43%
Research & Development $2.775M $415.0K
YoY Change 568.67% -48.32%
% of Gross Profit 11.31%
Depreciation & Amortization $445.0K $0.00
YoY Change -100.0%
% of Gross Profit 1.81%
Operating Expenses $20.30M $1.623M
YoY Change 1150.59% -68.58%
Operating Profit $4.233M -$1.623M
YoY Change -360.81% -68.58%
Interest Expense $523.0K $50.00K
YoY Change 946.0% -82.33%
% of Operating Profit 12.36%
Other Income/Expense, Net -$598.0K -$1.333M
YoY Change -55.14% 133200.0%
Pretax Income $3.930M -$1.576M
YoY Change -349.37% -67.73%
Income Tax $1.074M $0.00
% Of Pretax Income 27.33%
Net Earnings $2.856M -$1.576M
YoY Change -281.22% -67.73%
Net Earnings / Revenue 11.21%
Basic Earnings Per Share $0.01 -$0.04
Diluted Earnings Per Share $0.01 -$0.04
COMMON SHARES
Basic Shares Outstanding 93.52M 93.42M 37.97M
Diluted Shares Outstanding 102.6M 37.98M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.09M $2.200M
YoY Change 1040.55% -90.48%
Cash & Equivalents $15.90M $2.200M
Short-Term Investments $9.226M
Other Short-Term Assets $1.513M $1.700M
YoY Change -11.0% -21.15%
Inventory $6.379M
Prepaid Expenses
Receivables $19.49M $0.00
Other Receivables $1.287M $1.200M
Total Short-Term Assets $54.81M $5.132M
YoY Change 967.99% -83.03%
LONG-TERM ASSETS
Property, Plant & Equipment $24.44M $0.00
YoY Change -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.700M
YoY Change
Other Assets $2.766M $168.0K
YoY Change 1546.43% 0.0%
Total Long-Term Assets $70.43M $4.832M
YoY Change 1357.6% 525.1%
TOTAL ASSETS
Total Short-Term Assets $54.81M $5.132M
Total Long-Term Assets $70.43M $4.832M
Total Assets $125.2M $9.964M
YoY Change 1156.92% -67.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $303.0K $158.0K
YoY Change 91.77% 285.37%
Accrued Expenses $10.25M $1.600M
YoY Change 540.44% -0.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.72M $1.783M
YoY Change 725.35% 8.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.000K $4.700M
YoY Change -99.96%
Total Long-Term Liabilities $2.000K $4.700M
YoY Change -99.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.72M $1.783M
Total Long-Term Liabilities $2.000K $4.700M
Total Liabilities $26.77M $6.447M
YoY Change 315.17% 292.15%
SHAREHOLDERS EQUITY
Retained Earnings -$73.40M -$414.7M
YoY Change -82.3% 11.93%
Common Stock $85.00K $37.00K
YoY Change 129.73% 19.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $63.18M $3.517M
YoY Change
Total Liabilities & Shareholders Equity $125.2M $9.964M
YoY Change 1156.92% -67.88%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income $2.856M -$1.576M
YoY Change -281.22% -67.73%
Depreciation, Depletion And Amortization $445.0K $0.00
YoY Change -100.0%
Cash From Operating Activities $1.726M -$3.200M
YoY Change -153.94% -56.03%
INVESTING ACTIVITIES
Capital Expenditures $696.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.691M $0.00
YoY Change
Cash From Investing Activities -$2.387M $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 324.0K -1.400M
YoY Change -123.14% -96.89%
NET CHANGE
Cash From Operating Activities 1.726M -3.200M
Cash From Investing Activities -2.387M 0.000
Cash From Financing Activities 324.0K -1.400M
Net Change In Cash -337.0K -4.600M
YoY Change -92.67% -91.21%
FREE CASH FLOW
Cash From Operating Activities $1.726M -$3.200M
Capital Expenditures $696.0K
Free Cash Flow $1.030M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
93521434
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15866000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33509000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
9226000
CY2024Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
19487000
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
15552000
CY2024Q3 us-gaap Inventory Net
InventoryNet
6379000
CY2023Q4 us-gaap Inventory Net
InventoryNet
4281000
CY2024Q3 gyre Prepaid Assets Current
PrepaidAssetsCurrent
1051000
CY2023Q4 gyre Prepaid Assets Current
PrepaidAssetsCurrent
1547000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1513000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1045000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
54809000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
57221000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24442000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23288000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
184000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
205000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1984000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
489000
CY2024Q3 gyre Land Use Rights Net Noncurrent
LandUseRightsNetNoncurrent
1479000
CY2023Q4 gyre Land Use Rights Net Noncurrent
LandUseRightsNetNoncurrent
1493000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5161000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4695000
CY2024Q3 gyre Long Term Certificates Of Deposit
LongTermCertificatesOfDeposit
29515000
CY2023Q4 gyre Long Term Certificates Of Deposit
LongTermCertificatesOfDeposit
23431000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2766000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
995000
CY2024Q3 us-gaap Assets
Assets
125240000
CY2023Q4 us-gaap Assets
Assets
116539000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
303000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
355000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
36000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
39000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1288000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1369000
CY2023Q4 gyre Cvr Excess Closing Cash Payable
CvrExcessClosingCashPayable
1085000
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
9553000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
11935000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2842000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5054000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
694000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
210000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14716000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20047000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1101000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
199000
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
185000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
213000
CY2024Q3 gyre Cvr Derivative Liability Noncurrent
CVRDerivativeLiabilityNoncurrent
4900000
CY2023Q4 gyre Cvr Derivative Liability Noncurrent
CVRDerivativeLiabilityNoncurrent
4722000
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
5862000
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
12835000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
49000
CY2024Q3 us-gaap Liabilities
Liabilities
26766000
CY2023Q4 us-gaap Liabilities
Liabilities
38065000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85769526
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85769526
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76595616
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76595616
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
85000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
77000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
134296000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
68179000
CY2024Q3 gyre Statutory Reserve
StatutoryReserve
3098000
CY2023Q4 gyre Statutory Reserve
StatutoryReserve
3098000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73354000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-85538000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-946000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1644000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
63179000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-15828000
CY2024Q3 us-gaap Minority Interest
MinorityInterest
35295000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
29777000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
98474000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13949000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
125240000
dei Entity Central Index Key
EntityCentralIndexKey
0001124105
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 gyre Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2027-03
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51173
dei Entity Registrant Name
EntityRegistrantName
Gyre Therapeutics, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2020050
dei Entity Address Address Line1
EntityAddressAddressLine1
12770 High Bluff Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
567-7770
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
GYRE
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
116539000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25488000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32042000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
77885000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86302000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
958000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1184000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2707000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3386000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13699000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13928000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
40655000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
44695000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2775000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3009000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8312000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9212000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3823000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1157000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10645000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4607000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
21255000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
19278000
us-gaap Costs And Expenses
CostsAndExpenses
62319000
us-gaap Costs And Expenses
CostsAndExpenses
61900000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4233000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
12764000
us-gaap Operating Income Loss
OperatingIncomeLoss
15566000
us-gaap Operating Income Loss
OperatingIncomeLoss
24402000
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
523000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
283000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1201000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
718000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-598000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1333000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1226000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1281000
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
228000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6973000
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-526000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-68000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-526000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3930000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11188000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22446000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23313000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3678000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5117000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7816000
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2856000
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
7510000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
17329000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
15497000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1732000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3534000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5145000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7424000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1124000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3976000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12184000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8073000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85643646
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63588119
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84807041
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63588119
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102640373
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78904324
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102505585
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78907695
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2856000
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
7510000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
17329000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
15497000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1632000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
340000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1071000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2396000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4488000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7850000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
18400000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13101000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1732000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3534000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5145000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7424000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
568000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
153000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
373000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
-1060000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2300000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3687000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
5518000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
6364000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2188000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4163000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12882000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6737000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13949000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
492000
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
64525000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-141000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
9935000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
88771000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
441000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-420000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
4538000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
93346000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
237000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
374000
CY2024Q3 gyre Cvr Liability Settlement
CvrLiabilitySettlement
29000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1632000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2856000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
98474000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
72217000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
898000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4217000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
77332000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3634000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3770000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
77468000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
340000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
7510000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
85318000
us-gaap Profit Loss
ProfitLoss
17329000
us-gaap Profit Loss
ProfitLoss
15497000
us-gaap Share Based Compensation
ShareBasedCompensation
264000
gyre Equity Gain Loss Of Unconsolidated Affiliates
EquityGainLossOfUnconsolidatedAffiliates
-20000
gyre Equity Gain Loss Of Unconsolidated Affiliates
EquityGainLossOfUnconsolidatedAffiliates
-1166000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1088000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
776000
gyre Noncash Lease Expense
NoncashLeaseExpense
445000
gyre Noncash Lease Expense
NoncashLeaseExpense
346000
gyre Amortization Of Land Use Rights
AmortizationOfLandUseRights
29000
gyre Amortization Of Land Use Rights
AmortizationOfLandUseRights
30000
gyre Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
-410000
gyre Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
-757000
gyre Bad Debt Expense And Other Non Cash Items
BadDebtExpenseAndOtherNonCashItems
99000
gyre Bad Debt Expense And Other Non Cash Items
BadDebtExpenseAndOtherNonCashItems
-62000
gyre Accrued Interest On Certificates Of Deposit
AccruedInterestOnCertificatesOfDeposit
775000
gyre Accrued Interest On Certificates Of Deposit
AccruedInterestOnCertificatesOfDeposit
455000
gyre Change In Fair Value Of Long Term Receivables
ChangeInFairValueOfLongTermReceivables
178000
gyre Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
178000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6973000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-68000
gyre Increase Decrease In Accounts And Notes Receivables
IncreaseDecreaseInAccountsAndNotesReceivables
3813000
gyre Increase Decrease In Accounts And Notes Receivables
IncreaseDecreaseInAccountsAndNotesReceivables
-2651000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2021000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1563000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1783000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
649000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-2231000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
3188000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-55000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-105000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-779000
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-82000
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
529000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3500000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-46000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
1421000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-361000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-883000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22532000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
68000
us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
14074000
us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
14335000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2380000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6193000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
263000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
497000
gyre Payment For Equity Method Investment
PaymentForEquityMethodInvestment
1686000
gyre Payment For Equity Method Investment
PaymentForEquityMethodInvestment
1000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17880000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21099000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
169000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1307000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1138000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-18000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-529000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17643000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
904000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33509000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25175000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15866000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26079000
gyre Convertible Preferred Stock Conversion
ConvertiblePreferredStockConversion
64525000
gyre Non Cash Acquisition Of Property And Equipment Through Prepaid Conversion
NonCashAcquisitionOfPropertyAndEquipmentThroughPrepaidConversion
371000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7757000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5385000
us-gaap Net Income Loss
NetIncomeLoss
17300000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-900000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73400000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15900000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, allowance of doubtful accounts, long-term receivable, contingent value right (“CVR”) derivative liability, warrant liability, allowance for credit losses, reserves for excess or obsolete inventory, operating lease right-of-use assets and liabilities, recognition of research and development expenses to the appropriate financial reporting period based on the progress of the research and development projects, income taxes, stock-based compensation and useful lives of property and equipment and intangibles with definite lives. The Company bases its estimates on various assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In May 2015, a new Deposit Insurance System (“DIS”) managed by the People</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">’</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">s Bank of China was implemented by the Chinese government. Deposits in the licensed banks in mainland China are protected by DIS, up to a limit of Chinese Renminbi (“RMB”) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company maintains cash and deposits at commercial banks in excess of the amount protected by DIS and the Federal Deposit Insurance Corporation and in the event of bankruptcy of one of these financial institutions, the Company may be unable to claim its deposits back in full. Management believes that these financial institutions are of high credit quality and continually monitors the creditworthiness of these financial institutions. As of September 30, 2024 and December 31, 2023, the Company had cash and cash equivalents of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">33.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and long-term certificates of deposit of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">29.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">23.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively. In addition, the Company had short-term bank deposits of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> as of September 30, 2024. For the periods ended September 30, 2024 and December 31, 2023, cash and cash equivalents, short-term bank deposits and long-term certificates of deposits exceeded the PRC DIS coverage by </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">49.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">49.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounts receivable are typically unsecured and are derived from product sales. The Company manages credit risk related to the accounts receivable through ongoing monitoring of outstanding balances and limiting the amount of credit extended based upon payment history and creditworthiness. Historically, the Company has collected receivables from customers within the credit terms with no significant credit losses incurred.</span></p>
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15900000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33500000
CY2024Q3 gyre Long Term Certificates Of Deposit
LongTermCertificatesOfDeposit
29500000
CY2023Q4 gyre Long Term Certificates Of Deposit
LongTermCertificatesOfDeposit
23400000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
9200000
CY2024Q3 gyre Value Of Assets Exceeding Deposit Insurance System Limit
ValueOfAssetsExceedingDepositInsuranceSystemLimit
49700000
CY2023Q4 gyre Value Of Assets Exceeding Deposit Insurance System Limit
ValueOfAssetsExceedingDepositInsuranceSystemLimit
49400000
CY2024Q3 gyre Percentage Of Cash And Cash Equivalents Reporting Currency Denominated
PercentageOfCashAndCashEquivalentsReportingCurrencyDenominated
0.727
CY2024Q3 gyre Percentage Of Short Term Bank Deposits And Long Term Certificates Of Deposit Reporting Currency Denominated
PercentageOfShortTermBankDepositsAndLongTermCertificatesOfDepositReportingCurrencyDenominated
1
CY2024Q3 gyre Cash And Cash Equivalents Reporting Currency Denominated Value
CashAndCashEquivalentsReportingCurrencyDenominatedValue
11500000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
9200000
CY2024Q3 gyre Long Term Certificates Of Deposit
LongTermCertificatesOfDeposit
29500000
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
8083000
CY2024Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
10762000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
10582000
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
17557000
CY2024Q3 gyre Fair Value Assets And Liabilities Level1 To Level2 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2023Q4 gyre Fair Value Assets And Liabilities Level1 To Level2 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2023Q4 gyre Fair Value Assets And Liabilities Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel3TransfersAmount
0
CY2024Q3 gyre Fair Value Assets And Liabilities Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel3TransfersAmount
0
CY2024Q3 gyre Warrants Share Price
WarrantsSharePrice
12.54
CY2023Q4 gyre Warrants Share Price
WarrantsSharePrice
25.7
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4915
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4915
CY2024Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P9Y29D
CY2023Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P9Y9M29D
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3183000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3183000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3183000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5860000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5860000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5860000
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5000
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
46000
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1039000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
919000
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
3537000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1997000
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1803000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1365000
CY2024Q3 us-gaap Inventory Net
InventoryNet
6379000
CY2023Q4 us-gaap Inventory Net
InventoryNet
4281000
CY2024Q3 gyre Accrued Payroll And Welfare
AccruedPayrollAndWelfare
4914000
CY2023Q4 gyre Accrued Payroll And Welfare
AccruedPayrollAndWelfare
5790000
CY2024Q3 gyre Accrued Expenses Selling Expenses
AccruedExpensesSellingExpenses
1054000
CY2023Q4 gyre Accrued Expenses Selling Expenses
AccruedExpensesSellingExpenses
44000
CY2024Q3 gyre Supplier Reimbursement
SupplierReimbursement
1351000
CY2023Q4 gyre Supplier Reimbursement
SupplierReimbursement
2247000
CY2024Q3 gyre Accrued Expenses General And Administrative
AccruedExpensesGeneralAndAdministrative
924000
CY2023Q4 gyre Accrued Expenses General And Administrative
AccruedExpensesGeneralAndAdministrative
1190000
CY2024Q3 gyre Accrued Sales Discount
AccruedSalesDiscount
879000
CY2023Q4 gyre Accrued Sales Discount
AccruedSalesDiscount
903000
CY2024Q3 gyre Accrued Expenses Research And Development
AccruedExpensesResearchAndDevelopment
215000
CY2023Q4 gyre Accrued Expenses Research And Development
AccruedExpensesResearchAndDevelopment
161000
CY2024Q3 gyre Deferred Government Grants
DeferredGovernmentGrants
40000
CY2023Q4 gyre Deferred Government Grants
DeferredGovernmentGrants
40000
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
14000
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
648000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
837000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
162000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
75000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9553000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11935000
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
19538000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
15204000
CY2024Q3 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
91000
CY2023Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
389000
CY2024Q3 gyre Accounts And Financing Receivable Allowance For Credit Loss Current
AccountsAndFinancingReceivableAllowanceForCreditLossCurrent
142000
CY2023Q4 gyre Accounts And Financing Receivable Allowance For Credit Loss Current
AccountsAndFinancingReceivableAllowanceForCreditLossCurrent
41000
CY2024Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
19487000
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
15552000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29765000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27553000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5323000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4265000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24442000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23288000
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
1700000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
611000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
427000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
184000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
601000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
396000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
205000
CY2024Q3 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P4Y7M6D
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
107000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
9000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
35000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
35000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
34000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
19000
CY2024Q3 gyre Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
52000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
184000
gyre Percentage Of Revenue Accounted Sales To Distributors
PercentageOfRevenueAccountedSalesToDistributors
1
CY2024Q2 gyre Square Meter Area For Office Space Under Lease
SquareMeterAreaForOfficeSpaceUnderLease
2130
CY2024Q2 gyre Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2027-06
CY2022Q4 gyre Square Meter Area For Laboratory Center Under Lease
SquareMeterAreaForLaboratoryCenterUnderLease
180
CY2022 gyre Lease Renewed Month And Year
LeaseRenewedMonthAndYear
2024-07
CY2022 gyre Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2026-08
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
19000
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
22000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
54000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
72000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2000000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1800000
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
us-gaap Operating Lease Expense
OperatingLeaseExpense
500000
us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
us-gaap Operating Lease Payments
OperatingLeasePayments
631000
us-gaap Operating Lease Payments
OperatingLeasePayments
364000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0476
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0478
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
240000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
766000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
617000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
286000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1909000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
114000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1795000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
694000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1101000
CY2024Q3 us-gaap Security Deposit
SecurityDeposit
300000
CY2024Q3 gyre Combined Square Meter Area For Manufacturing Facilities Under Lease
CombinedSquareMeterAreaForManufacturingFacilitiesUnderLease
66559
CY2024Q3 gyre Land Use Rights Net Assets
LandUseRightsNetAssets
1500000
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
19086286
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
27588546
CY2024Q3 gyre Aggregate Amounts Of Restricted Capital And Statutory Reserves
AggregateAmountsOfRestrictedCapitalAndStatutoryReserves
64300000
CY2023Q4 gyre Aggregate Amounts Of Restricted Capital And Statutory Reserves
AggregateAmountsOfRestrictedCapitalAndStatutoryReserves
64300000
gyre Statutory Reserve Fund
StatutoryReserveFund
0.10
gyre Cumulative Amount Of Statutory Reserve Fund
CumulativeAmountOfStatutoryReserveFund
0.50
gyre Appropriations To Statutory Reserve
AppropriationsToStatutoryReserve
0
CY2023 gyre Appropriations To Statutory Reserve
AppropriationsToStatutoryReserve
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18280548
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.49
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
680732
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
406577
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9083
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
16.24
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18545620
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
17867835
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.7
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y7M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
237000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
264000
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2856000
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
7510000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
17329000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
15497000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1732000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3534000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5145000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7424000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1124000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3976000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12184000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8073000
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
228000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6973000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1352000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3976000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5211000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
8073000
CY2024Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
85643646
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
63588119
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
84807041
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
63588119
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85643646
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63588119
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84807041
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63588119
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16765219
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
15316205
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16722627
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
15319576
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
703946
CY2024Q3 gyre Weighted Average Of Preferred Stock Warrant
WeightedAverageOfPreferredStockWarrant
231508
gyre Weighted Average Of Preferred Stock Warrant
WeightedAverageOfPreferredStockWarrant
271971
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102640373
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78904324
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102505585
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78907695
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
922960
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
870386
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3678000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5117000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7816000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2733
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3287
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.228
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3353
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25488000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
958000
CY2024Q3 us-gaap Gross Profit
GrossProfit
24530000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13699000
CY2024Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2775000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3823000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
20297000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4233000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
237000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
77885000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2707000
us-gaap Gross Profit
GrossProfit
75178000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
40655000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
8312000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10645000
us-gaap Operating Expenses
OperatingExpenses
59612000
us-gaap Operating Income Loss
OperatingIncomeLoss
15566000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32042000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1184000
CY2023Q3 us-gaap Gross Profit
GrossProfit
30858000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13928000
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
3009000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1157000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
18094000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
12764000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86302000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3386000
us-gaap Gross Profit
GrossProfit
82916000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
44695000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
9212000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4607000
us-gaap Operating Expenses
OperatingExpenses
58514000
us-gaap Operating Income Loss
OperatingIncomeLoss
24402000
CY2024Q3 us-gaap Assets
Assets
125240000
CY2023Q4 us-gaap Assets
Assets
116539000
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
2380000
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
6193000

Files In Submission

Name View Source Status
0000950170-24-126306-index-headers.html Edgar Link pending
0000950170-24-126306-index.html Edgar Link pending
0000950170-24-126306.txt Edgar Link pending
0000950170-24-126306-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gyre-20240930.htm Edgar Link pending
gyre-20240930.xsd Edgar Link pending
gyre-ex31_1.htm Edgar Link pending
gyre-ex31_2.htm Edgar Link pending
gyre-ex32_1.htm Edgar Link pending
gyre-ex32_2.htm Edgar Link pending
gyre-ex3_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gyre-20240930_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending